Menu Close

Articles on Public health

Displaying 801 - 820 of 2123 articles

Study shows that the Novavax vaccine is effective against the dominant variant of COVID-19 in South Africa. Jakub Porzycki/NurPhoto via Getty Images

Results from Novavax vaccine trials in the UK and South Africa differ: why, and does it matter?

The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
Health care workers and patients in the temporary outside area Steve Biko Academic Hospital created to screen and treat suspected Covid-19 cases in Pretoria. Alet Pretorius/Gallo Images via Getty Images

South African scientists who discovered new COVID-19 variant share what they know

Scientists have observed that 501Y.V2 has quickly become “dominant” among multiple variants that have been circulating in the South African population.
Vaccine hesitancy is a growing public health problem. Sharon Seretlo/Gallo Images via Getty Images

South Africa’s immunisation record risks being dented by anti-vaccination views

Vaccine hesitancy has resulted in multiple vaccine-preventable disease outbreaks. Research on vaccine hesitancy in South Africa is limited. But growing evidence suggests that it’s becoming a problem.

Top contributors

More